Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
Anti-psychotics are the mainstay of treatment for Schizophrenia and psychotic disorders. Historically, anticholinergics have been prescribed to prevent or treat extrapyramidal side effects (EPS) associated with first-generation antipsychotics (FGAs). Even though newer antipsychotics are associated w...
| Main Authors: | , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| 叢編: | Industrial Psychiatry Journal |
| 主題: | |
| 在線閱讀: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2022;volume=31;issue=2;spage=370;epage=373;aulast=Chatterjee |